Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of CL2020 in ST-elevation acute myocardial infarction
jRCT1080223778Phase 2Completed
- Sponsor
- Life Science Institute
- Start
- Jan 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of CL2020 in myocardial infarction (MI), sponsored by Life Science Institute. Primary endpoint: Safety over 52 weeks. Started Jan 2018; status: completed.
02
Drugs
CL2020
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on jRCT1080223778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223778.